Dissemin is shutting down on January 1st, 2025

Published in

BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, 1(7), 2019

DOI: 10.1186/s40425-018-0470-3

Links

Tools

Export citation

Search in Google Scholar

EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO